FIELD: pharmacology.
SUBSTANCE: composition contains Cenicriviroc or its salt and fumaric acid. A method of preparation of the said composition, a pill, a method for preparation of the said pill and a method for treatment of a disease, disorder or condition, comprising administration of a therapeutically effective amount of the said composition or pill, is described.
EFFECT: group of inventions can be used to treat viral infection, inflammation, fibrosis or graft-versus-host syndrome.
138 cl, 14 dwg, 36 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED THERAPY WITH APPLICATION OF CENICRIVIROC FOR FIBROSIS TREATMENT | 2015 |
|
RU2723559C2 |
| CENICRIVIROC FOR TREATING FIBROSIS | 2015 |
|
RU2724339C2 |
| TWO-LAYER PHARMACEUTICAL DOSAGE FORM OF TABLETS | 2018 |
|
RU2803050C2 |
| CENICRIVIROC FOR TREATING LIVER AND PERITONITIS DISEASES | 2015 |
|
RU2722641C2 |
| PHARMACEUTICAL PREPARATION FOR ORAL USE BASED ON RALOXYPHENE OR ITS DERIVATIVES | 1995 |
|
RU2118540C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR | 2006 |
|
RU2404775C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
| PHARMACEUTICAL COMPOSITION WITH TELMISARTAN SODIUM SALT | 2004 |
|
RU2372918C2 |
| NEW PHARMACEUTICAL COMPOSITIONS EFFECTIVE IN TREATING PARKINSON'S DISEASE | 2006 |
|
RU2440100C2 |
